Important Safety Information
Prescribing Information for Benzyl Alcohol Formulation | Prescribing Information for MGPC Formulation
 
 
 
 

  • Home Page
  • Joint Pain
    • Osteoarthritis Pain
    • Joint Injury Pain
  • Treating Joint Pain
    • Treating Osteoarthritis Pain
    • Treating Joint Injury Pain
  • DEPO-MEDROL
  • Getting Your Shot
  • Prescribing Information
  • Important Safety Information
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map

DEPO-MEDROL (methylprednisolone) is a corticosteroid that can be used to treat inflammatory disorders such as joint pain caused by an injury, or flares of pain associated with osteoarthritis (OA).

Important Safety Information:

Do not take DEPO-MEDROL if you are allergic to any of its ingredients.

DEPO-MEDROL should not be used in premature infants, or in patients with systemic fungal infections.

Do not stop using DEPO-MEDROL abruptly or without the approval of your doctor. You should also tell any doctors that you see that you are taking a corticosteroid. If you develop a fever or other signs of infection, you should call a doctor right away.

When taking DEPO-MEDROL you should avoid exposure to chicken pox or measles. If you think you were exposed, you should call a doctor immediately.

DEPO-MEDROL may mask some signs of infection, and new infections may appear during its use. These infections may be mild, but can be severe and at times fatal. With increasing doses of DEPO-MEDROL, the rate of occurrence of infectious complications increases. Injection of DEPO-MEDROL may result in changes in the skin at the injection site like dips or dents. Prolonged use of corticosteroids may produce eye damage. Average and large doses of corticosteroids can cause elevation of blood pressure, salt and water retention, and increased excretion of potassium.

As with all corticosteroids, DEPO-MEDROL has been associated with allergic skin reactions, erythema, and tendon rupture. Hyperglycemia, osteoporosis, psychiatric disorders, myopathy, and the stunting of growth may also occur.

Please see full prescribing information for the benzyl alcohol formulation of DEPO-MEDROL

Please see full prescribing information for the MGPC formulation of DEPO-MEDROL

Pfizer Helpful Answers

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

Pfizer.com | Terms of Use | Privacy Policy | Contact Us | Site Map

Click here to go to www.pfizer.com
  © 2009-2010 Pfizer Inc. All rights reserved.

  Pfizer is a licensee of the TRUSTe Privacy Program.
 DME00022